Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Public Health
56.13% of people in Delhi developed antibodies
Life Sciences Times
-
February 2, 2021
0
Pharma
Pfizer-BioNTech to produce 2 billion doses of Covid vaccine in 2021
Life Sciences Times
-
February 2, 2021
0
Life Sciences
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
Life Sciences Times
-
February 1, 2021
0
Pharma
Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial
Life Sciences Times
-
February 1, 2021
0
Pharma
Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated
Life Sciences Times
-
February 1, 2021
0
Biotech
MOMA Therapeutics Appoints Asit Parikh as President and Chief Executive Officer
Life Sciences Times
-
February 1, 2021
0
Real Estate
IQHQ Expands Leadership Team to Support Rapid Growth of Life Sciences Commercial Real Estate Portfolio
Life Sciences Times
-
February 1, 2021
0
Public Health
US CDC makes masks mandatory on planes, public transportation
Life Sciences Times
-
February 1, 2021
0
Public Health
US Covid-19 cases, hospitalizations drop, deaths still spike
Life Sciences Times
-
February 1, 2021
0
Medtech
This alternative surgery may prevent total knee replacement
Life Sciences Times
-
February 1, 2021
0
1
...
784
785
786
...
805
Page 785 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026